KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Return on Equity: 2010-2014

Historic Return on Equity for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to -1.36%.

  • Biocryst Pharmaceuticals' Return on Equity fell 12.00% to -0.60% in Q3 2015 from the same period last year, while for Sep 2015 it was -0.60%, marking a year-over-year decrease of 12.00%. This contributed to the annual value of -1.36% for FY2014, which is 4617.00% down from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Return on Equity of -1.36% as of FY2014, which was down 103.04% from 44.81% recorded in FY2013.
  • Biocryst Pharmaceuticals' 5-year Return on Equity high stood at 44.81% for FY2013, and its period low was -5.34% during FY2012.
  • In the last 3 years, Biocryst Pharmaceuticals' Return on Equity had a median value of -1.36% in 2014 and averaged 12.70%.
  • Per our database at Business Quant, Biocryst Pharmaceuticals' Return on Equity surged by 5,015bps in 2013 and then crashed by 4,617bps in 2014.
  • Over the past 5 years, Biocryst Pharmaceuticals' Return on Equity (Yearly) stood at -0.45% in 2010, then slumped by 87bps to -1.32% in 2011, then slumped by 402bps to -5.34% in 2012, then spiked by 5,015bps to 44.81% in 2013, then tumbled by 4,617bps to -1.36% in 2014.